Ying Wang

Longitudinal analysis of antibody decay in convalescent COVID-19 patients

L. Kazis, N. Melikechi, W. Xia, 2021, Scientific Reports.

Clinical outcomes of COVID‐19 infection among patients with Alzheimer's disease or mild cognitive impairment

L. Kazis, L. Kazis, Weiming Xia, 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy

Yang Zhang, Kun Zhu, Qian Yu, 2020, Frontiers in Pharmacology.

Convalescent plasma may be a possible treatment for COVID-19: A systematic review

Shao-fei Yuan, Yi-Xian Guo, Ruiqin Li, 2020, International Immunopharmacology.

The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension

D. Berlowitz, L. Kazis, W. Xia, 2021, PloS one.

Specific Interleukin-1 Inhibitors, Specific Interleukin-6 Inhibitors, and GM-CSF Blockades for COVID-19 (at the Edge of Sepsis): A Systematic Review

Miao Li, Ruiqin Li, Kun Zhu, 2022, Frontiers in Pharmacology.

The COVID-19 Vaccination Behavior and Correlates in Diabetic Patients: A Health Belief Model Theory-Based Cross-Sectional Study in China, 2021

Jing Li, Jinping Zheng, Jianzhou Yang, 2022, Vaccines.

The Association Between the Albumin and Viral Negative Conversion Rate in Patients Infected with Novel Coronavirus Disease 2019 (COVID-19)

Peng Meng, Shanfeng Zhu, L. Lang, 2022, Infection and drug resistance.

Diarrhoea after treatment: an adverse drug reaction in patients with COVID-19

Xusheng An, Xiao-Zhong Yang, Honggang Wang, 2020 .